Skip to content
Tuesday, November 10, 2026
Discover expert tips, strategies, and reviews for maximizin…

Users Stopping Anti-Obesity Medications Regain Weight at a Quadrupled Rate Compared to Dieters

Image of medical injection and weighing machine
Weight management often requires long-term strategies.

New research suggests that individuals who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who halt traditional diet and exercise programs.

Findings released in a leading medical journal shows that while obese people can lose a large proportion of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Users buying such medications must be cognizant of the risk of quick rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery means a return to pre-treatment weight in about one and a half years.

Comparing Therapies

The study, which examined 37 of studies involving thousands of participants, compared the results of the injectable medications with older methods.

The team emphasize that individuals who shed pounds through diet and exercise generally have a slower weight regain—approximately 100 grams monthly—once they finish.

Explaining the Fast Rebound

Nutrition scientists believe the mode of action of the drugs explains the heightened weight return.

The injections mimic a natural hormone called GLP-1, which moderates feelings of fullness.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication leads to hunger is no longer kept in check, making binge eating a significant risk."

An Ongoing Disease?

Medical guidelines recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the high risk of weight regain, the treatment is often life-long.

This perspective is supported by drug manufacturers, who say that the findings "underscore the chronic character of excess weight," comparing it to managing diseases like hypertension.

Patient Testimonies

People who have stopped the medication describe a powerful resurgence of appetite.

"It felt as if a switch activating and I was suddenly extremely hungry," described a patient.

This difficulty is compounded if users have not adopted lasting dietary or behavioural modifications during therapy.

Widespread Interest

Figures show that millions of adults in the UK have used weight-loss jabs in the past year, with interest being substantial.

  • Adoption is higher among women than males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while the jabs are powerful tools for weight loss, they are not a permanent fix and maintained weight loss relies on combined lifestyle support.

Written by

Johnny Vasquez

A seasoned gaming analyst with over a decade of experience in online casino strategies and jackpot optimization.

Rapid Jackpot Network

Type to search articles.